Home›Research›Compare›ARA-290 vs Retinalamin
Peptide ComparisonARA-290 vs Retinalamin
Both are Longevity & Cellular peptides.
ARA-290
Cibinetide
Half-life: ~2 min (IV); ~10–20 min (SC)
16 providers listed
Retinalamin
Retinal bioregulator
Half-life: Unknown
1 providers listed
ARA-290 carries stronger published evidence (RCT, 3 key studies) than Retinalamin (Review, 2); both are research compounds.
ARA-290
Evidence
Half-life
~2 min (IV); ~10–20 min (SC)
Retinalamin
Evidence
Half-life
Unknown
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | ARA-290 |
| Further along in FDA review | ARA-290 |
| More provider options (16 vs 1) | ARA-290 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
ARA-290
Retinalamin
ARA-290
Immunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.
Cibinetide (ARA 290) reduces small nerve fiber pathology in sarcoidosis patients
ARA 290, a non-hematopoietic erythropoietin analogue, improves metabolic control and neuropathic symptoms in…
Retinalamin
Peptide Regulation of Gene Expression and Protein Synthesis in Bronchial Epithelium
Bioavailability and Biological Activities of Food-Derived Di- and Tripeptides: In Silico and In Vitro Studies
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
About Retinalamin
Polypeptide bioregulator from bovine retina; normalizes retinal pigment epithelial and photoreceptor cell function; reduces oxidative damage in retinal tissue
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
ARA-290
No established clinical contraindications
Retinalamin
No established clinical contraindications
ARA-290
Retinalamin
Not enough vendor pricing yet.
Where to source these peptides
ARA-290
16 listed
Browse directory →
Providers offeringRetinalamin
1 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). ARA-290 vs Retinalamin — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/ara-290/retinalamin